Acorda Therapeutics reported $23.13M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Acorda Therapeutics ACOR:US $ 23.13M 8.75M
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
ALKERMES ALKS:US $ 254.65M 27.91M
Amgen AMGN:US $ 5203M 1325M
Anika Therapeutics ANIK:US $ 91.39M 1.07M
Aptinyx Inc APTX:US $ 85.27M 14.89M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Biogen BIIB:US $ 2646.6M 897.3M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Cara Therapeutics CARA:US $ 46.72M 25.36M
Clovis Oncology CLVS:US $ 94.58M 27.66M
Cytokinetics CYTK:US $ 93.63M 21.79M
Enanta Pharmaceuticals ENTA:US $ 28.37M 12.62M
Gilead Sciences GILD:US $ 7000M 2704M
GlaxoSmithKline GSK:LN 646500M 450200M
Halozyme Therapeutics HALO:US $ 90.93M 26.9M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Insmed INSM:US $ 416.08M 99.63M
Ligand Pharmaceuticals LGND:US $ 153.22M 138.22M
Mannkind MNKD:US $ 35.51M 31.74M
Merck MRK:GR € 1580M 241M
Moderna Inc MRNA:US 2.87B 2.18B
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Novartis NOVN:VX SF 3625M 10227M
Teva Pharmaceutical TEVA:IT 2.06B 117M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M